Last reviewed · How we verify

NCT05456711

Femoral Cartilage Thickness in Knee Osteoarthritis

Status unknown Last updated 13 July 2022
What this trial tests

trial testing ultrasonographic measurement for femoral cartilage thickness VAS for pain severity WOMAC for functionality in Knee Osteoarthritis in 140 participants. Status unknown.

Timeline
15 May 2022
Primary endpoint
15 July 2022
15 July 2022

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment140
Start date15 May 2022
Primary completion15 July 2022
Estimated completion15 July 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 50 to 65, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study to investigate the relationship between femoral cartilage thickness in Ultrasonographic evaluation and inflammatory parameters, pain severity and functionality in participants with Knee Osteoarthritis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05456711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing